Analystreport

Osmotica Pharmaceuticals plc (NASDAQ: OSMT) had its price target lowered by analysts at Truist from $7.00 to $5.00. They now have a "buy" rating on the stock.

Osmotica Pharmaceuticals plc - Ordinary Shares  (OSMT) 
Last osmotica pharmaceuticals plc - ordinary shares earnings: 3/18 04:05 pm Check Earnings Report